Johnson & Johnson has released its Q4 2019 results, as well as the entire fiscal year’s financials. The company projects continued sales and earnings growth in fiscal year 2020.
- Worldwide sales increased by 1.7% to $20.7 billion
- Consumer sales increased by 0.9% to $3.56 billion
2019 fiscal year
- Worldwide sales increased 0.6% to $82.1 billion
- Consumer sales increased 0.3% to $13.89 billion
“We delivered strong underlying sales and earnings growth in 2019, driven by the strength of our pharmaceutical business, accelerating performance in our medical devices business and improved profitability in our consumer business,” said Alex Gorsky, chairman and CEO. “As we enter into 2020 and this next decade, our strategic investments focused on advancing our pipelines and driving innovation across our entire product portfolio, position us well to deliver long-term sustainable growth and value to our shareholders.”
“I am extremely proud of our talented and dedicated colleagues who live our credo values each and every day, and are inspired to deliver transformative healthcare solutions that improve the lives of our patients and consumers around the world.”